Company Analysis China Resources Medical Holdings Company Limited
1. Summary
Disadvantages
- Price (4.08 HK$) is higher than fair price (2.07 HK$)
- Dividends (1.97%) are below the sector average (5.7%).
- The stock's return over the last year (3.82%) is lower than the sector average (15.22%).
- Current debt level 15.31% has increased over 5 years from 8.46%.
- The company's current efficiency (ROE=3.36%) is lower than the sector average (ROE=5.2%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
China Resources Medical Holdings Company Limited | Healthcare | Index | |
---|---|---|---|
7 days | -4% | -1.1% | -1.1% |
90 days | 4.3% | 12% | 21% |
1 year | 3.8% | 15.2% | 40.3% |
1515 vs Sector: China Resources Medical Holdings Company Limited has significantly underperformed the "Healthcare" sector by -11.4% over the past year.
1515 vs Market: China Resources Medical Holdings Company Limited has significantly underperformed the market by -36.45% over the past year.
Stable price: 1515 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 1515 with weekly volatility of 0.0734% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (4.08 HK$) is higher than the fair price (2.07 HK$).
Price is higher than fair: The current price (4.08 HK$) is 49.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (20.5) is lower than that of the sector as a whole (35.42).
P/E vs Market: The company's P/E (20.5) is lower than that of the market as a whole (26.64).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.7533) is lower than that of the sector as a whole (3.7).
P/BV vs Market: The company's P/BV (0.7533) is higher than that of the market as a whole (-11.94).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.5227) is lower than that of the sector as a whole (7.22).
P/S vs Market: The company's P/S indicator (0.5227) is lower than that of the market as a whole (2.71).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (10.45) is higher than that of the sector as a whole (2.91).
EV/Ebitda vs Market: The company's EV/Ebitda (10.45) is higher than that of the market as a whole (9.94).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -3.38% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-3.38%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (254.81%).
5.4. ROE
ROE vs Sector: The company's ROE (3.36%) is lower than that of the sector as a whole (5.2%).
ROE vs Market: The company's ROE (3.36%) is lower than that of the market as a whole (6.07%).
5.5. ROA
ROA vs Sector: The company's ROA (1.64%) is lower than that of the sector as a whole (3.48%).
ROA vs Market: The company's ROA (1.64%) is lower than that of the market as a whole (3.24%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 1.97% is below the average for the sector '5.7%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.97% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 1.97% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (16.44%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription